HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kirk R Gustafson Selected Research

discorhabdin W

1/2016Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kirk R Gustafson Research Topics

Disease

14Neoplasms (Cancer)
01/2021 - 11/2003
3Infections
12/2008 - 07/2003
2Colonic Neoplasms (Colon Cancer)
01/2016 - 11/2014
2Hypoxia (Hypoxemia)
04/2015 - 04/2011
2Kidney Neoplasms (Kidney Cancer)
09/2012 - 01/2009
2Human Influenza (Influenza)
12/2008 - 08/2003
1Alveolar Rhabdomyosarcoma
01/2024
1Lymphoma (Lymphomas)
01/2021
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
05/2020
1Adenocarcinoma of Lung
01/2017
1Warts (Wart)
04/2016
1Carcinoma (Carcinomatosis)
11/2014
1Carcinogenesis
09/2012
1Breast Neoplasms (Breast Cancer)
03/2009
1HIV Infections (HIV Infection)
01/2008
1Liver Diseases (Liver Disease)
09/2006

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2024 - 07/2003
4cyanovirin NIBA
12/2008 - 07/2003
3AlkaloidsIBA
04/2016 - 08/2014
2madecassic acidIBA
01/2019 - 01/2018
2discorhabdin HIBA
07/2018 - 01/2016
2discorhabdin LIBA
07/2018 - 01/2016
2LuciferasesIBA
01/2016 - 01/2012
2Transcription Factors (Transcription Factor)IBA
04/2015 - 09/2012
2Oxygen (Dioxygen)IBA
04/2015 - 04/2011
2CyclotidesIBA
11/2011 - 01/2008
2Antiviral Agents (Antivirals)IBA
09/2006 - 08/2003
1Ligases (Synthetase)IBA
01/2021
1SpermidineIBA
01/2021
1SpermineIBA
01/2021
1Terpenes (Terpenoids)IBA
01/2021
1Plant ExtractsIBA
01/2021
1tyrosyl-DNA phosphodiesteraseIBA
12/2020
1Irinotecan (Camptosar)FDA LinkGeneric
12/2020
1Topotecan (Hycamtin)FDA LinkGeneric
12/2020
1Topoisomerase InhibitorsIBA
12/2020
1sphaeropsidin AIBA
10/2020
1Peptide Hydrolases (Proteases)FDA Link
05/2020
1TriterpenesIBA
01/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017
110-deoxocapillosanane DIBA
04/2016
1SesquiterpenesIBA
04/2016
1verrupyrroloindolineIBA
04/2016
1cyclopentenoneIBA
04/2016
1verrubenzospirolactoneIBA
04/2016
1discorhabdin BIBA
01/2016
1discorhabdin WIBA
01/2016
1makaluvamine FIBA
01/2016
1Molecular Probes (Molecular Probe)IBA
04/2015
1Hypoxia-Inducible Factor 1IBA
04/2015
1Guanidine (Guanidine Nitrate)FDA Link
08/2014
1mirabilin GIBA
08/2014
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
04/2014
1Sirolimus (Rapamycin)FDA Link
04/2014
14- (5- acetyloxy- 8,8- dimethyl- 6- (3- methylbut- 2- en- 1- yl)- 4- oxo- 4,8- dihydropyrano(2,3- f)chromen- 3- yl)- 1,2- phenylene diacetateIBA
04/2014
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
04/2014
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2012
1Complex MixturesIBA
01/2012
1NF-kappa B (NF-kB)IBA
03/2009
1matrigelIBA
03/2009
12- (4- ((4- amino- 2- methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acidIBA
03/2009
1englerin AIBA
01/2009
1Ribavirin (Virazole)FDA LinkGeneric
12/2008
1PlacebosIBA
12/2008
1Polysaccharides (Glycans)IBA
09/2006
1Adenosine Triphosphatases (ATPase)IBA
11/2003
1Neuraminidase (Sialidase)IBA
08/2003
1Viral HemagglutininsIBA
08/2003

Therapy/Procedure

2Therapeutics
04/2014 - 09/2006
1Aftercare (After-Treatment)
12/2008